drugset / Trial / NCT01276223

Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients

NCT01276223

Phase 2 Completed 722 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study was to determine if difluprednate ophthalmic emulsion is effective in reducing the ocular symptoms of dry eye disease, as measured by a global Visual Analog Scale (VAS) discomfort score.

Timeline

Start
2011-02
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Difluprednate Small molecule 0.05 % Topical

Indications